0001562180-20-006034.txt : 20200917 0001562180-20-006034.hdr.sgml : 20200917 20200917174729 ACCESSION NUMBER: 0001562180-20-006034 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200917 FILED AS OF DATE: 20200917 DATE AS OF CHANGE: 20200917 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Duffy David C. CENTRAL INDEX KEY: 0001724566 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38319 FILM NUMBER: 201182059 MAIL ADDRESS: STREET 1: C/O QUANTERIX CORPORATION STREET 2: 113 HARTWELL AVENUELE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Quanterix Corp CENTRAL INDEX KEY: 0001503274 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 208957988 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 MIDDLESEX TURNPIKE CITY: BILLERICA STATE: MA ZIP: 01821 BUSINESS PHONE: 617-301-9400 MAIL ADDRESS: STREET 1: 900 MIDDLESEX TURNPIKE CITY: BILLERICA STATE: MA ZIP: 01821 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2020-09-17 false 0001503274 Quanterix Corp QTRX 0001724566 Duffy David C. C/O QUANTERIX CORPORATION, 900 MIDDLESEX TURNPIKE BILLERICA MA 01821 false true false false SVP R&D and CTO Common Stock 2020-09-17 4 S false 1667.00 32.43 D 44511.00 D The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on May 15, 2020. Includes 12,313 restricted stock units. /s/ Brian Keane, Attorney-in-fact 2020-09-17